Company news
Bioasis Technologies Inc. news in 2016
Bioasis Technologies Inc.'s news releases, calls and decks from 2016, newest first.
biOasis Attends BIO Europe and the Lockman BT2111 Paper is Honored by being Featured on the Cover of Pharmaceutical Research's December Journal
November 6, 2016
biOasis Provides Further Details Regarding its Agreement with Rising Tide Equity
October 25, 2016
biOasis Engages Rising Tide Equity to Increase Global Awareness
October 23, 2016
biOasis Enters Into a License Agreement With Vaccinex Inc.
September 20, 2016
biOasis Announces Publication of Scientific Paper -- Transcend-Based Anti-Cancer Antibody BT2111 Crosses the Blood-Brain Barrier and Shows Efficacy in the Treatment of Metastatic HER2+ Breast Cancer Tumors in the Brains of Animal Model
August 29, 2016
biOasis Announces the Issuance of an Additional US Patent for the Delivery of Therapeutic Agents Across the Blood-Brain Barrier
July 10, 2016
biOasis Technologies Enters Into a License Agreement With Astellas Research Institute of America LLC
April 21, 2016
biOasis to Present at the Brains for Brain 10th Annual Workshop and Open Conference in Madrid, Spain
March 17, 2016
biOasis Announces Shares for Services Settlement
February 29, 2016
biOasis Technologies Inc. to Present at the 1st Annual Neuroscience BioPartnering and Investment Forum in New York on February 23, 2016
February 11, 2016